
Tropicamide (CAS 1508-75-4) is a potent antimuscarinic agent used to induce short-acting mydriasis and cycloplegia for diagnostic ocular examinations.
In the competitive landscape of diagnostic ophthalmology, dilation efficiency and recovery time define the final outcome. Zyntex Tropicamide is selected for its ability to selectively block muscarinic receptors in the sphincter muscle of the iris and the ciliary muscle. Therefore, we provide a high-purity crystalline powder that acts as a robust mydriatic and cycloplegic agent. Consequently, this versatile ingredient delivers reliable performance across a wide range of clinical conditions, ensuring adequate pupil dilation for fundus examination and accurate refraction measurement in both pediatric and adult patients.
Zyntex supplies Tropicamide in a clean, white crystalline form, optimized for easy integration into complex liquid-dosage synthesis, including sterile eye drop solutions and multi-ingredient diagnostic sprays. Our stringent quality control measures ensure a precise impurity profile and strictly controlled solubility characteristics. Furthermore, this product features a rapid onset of action and a relatively short duration compared to atropine, enhancing patient comfort post-examination. Since it is effective at achieving maximum mydriasis within 20-40 minutes, you can incorporate it into various ophthalmic preparations without affecting the isotonic balance or the sterile stability of the final dosage form.
From specialized laboratory research to large-scale pharmaceutical manufacturing, this versatile tropane derivative is a staple for modern eye care. Its consistent chemical profile ensures it functions effectively as an anticholinergic with minimal systemic absorption when administered topically. As a result, Zyntex provides a dependable foundation for innovation in the “diagnostic ophthalmics” and “vision healthcare” markets. Finally, our commitment to chemical quality helps your brand achieve international pharmaceutical regulatory and safety standards effortlessly.
This professional-grade pharmaceutical API is widely utilized in the following sectors:
The primary active ingredient for dilating the pupil to facilitate thorough examination of the retina and vitreous humor.
Used to temporarily paralyze the ciliary muscle, allowing for precise determination of refractive errors.
Ideal for sterile aqueous solutions, often formulated at 0.5% or 1.0% concentrations for clinical use.
Used as a reference standard in pharmacological studies focusing on autonomic nervous system modulation in the eye.
| Parameter | Specification Standard |
|---|---|
| Product Name | Tropicamide |
| Assay (HPLC) | 99.0% – 101.0% |
| Physical State | White Crystalline Powder |
| Melting Point | 96°C – 100°C |
| CAS Number | 1508-75-4 |
🔬 Scientific Data: For detailed pharmacokinetics, mechanism of action, and toxicological profiles, consult: PubChem Entry: Tropicamide (External Link)